Payment overview · 2025
General Payments
$20.58
1 reported records · 1 companies
Healthcare provider profile · identity verified
Andre Scofield Marques, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · ALTAMONTE SPRINGS, FL · NPI 1144515917
Verified facts
What the public records show
CMS Open Payments records show Andre Scofield Marques, M.D. received $20.58 in general payments during 2025 across 1 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
A separate comparison found the same explicitly named product in public Medicare Part D data: Rexulti.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUEDEXTA as an associated drug or biological on 393 records involving 285 distinct recipient NPIs. Public Medicare Part D data also shows 34 claims for Nuedexta by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 160756 records involving 46288 distinct recipient NPIs. Public Medicare Part D data also shows 32 claims for Rexulti by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $20.58 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $20.58 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $20.58 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| REXULTI rexulti |
2025 | Rexulti | 2024 | 32 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | NUEDEXTA open payments reported associated product |
CMS Open Payments — General Payments 393 supporting records · 285 recipient NPIs · example record 1227268901 |
Nuedexta · 2024 Exact normalized brand match · 1 Part D row |
34 | 13 |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 160756 supporting records · 46288 recipient NPIs · example record 1227267708 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
32 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Eliquis | Apixaban | 1169 | 116 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1072 | 206 |
| Gabapentin | Gabapentin | 904 | 153 |
| Levothyroxine Sodium | Levothyroxine Sodium | 735 | 128 |
| Amlodipine Besylate | Amlodipine Besylate | 646 | 122 |
| Tamsulosin Hcl | Tamsulosin Hcl | 466 | 83 |
| Metoprolol Tartrate | Metoprolol Tartrate | 424 | 90 |
| Trazodone Hcl | Trazodone Hcl | 422 | 87 |
| Carvedilol | Carvedilol | 414 | 75 |
| Potassium Chloride | Potassium Chloride | 370 | 67 |
| Losartan Potassium | Losartan Potassium | 360 | 69 |
| Clopidogrel | Clopidogrel Bisulfate | 348 | 72 |
| Furosemide | Furosemide | 345 | 79 |
| Divalproex Sodium | Divalproex Sodium | 339 | 70 |
| Donepezil Hcl | Donepezil Hcl | 339 | 57 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 334 | 66 |
| Pantoprazole Sodium | Pantoprazole Sodium | 326 | 79 |
| Mirtazapine | Mirtazapine | 320 | 80 |
| Metformin Hcl | Metformin Hcl | 304 | 59 |
| Levetiracetam | Levetiracetam | 296 | 46 |
| Lisinopril | Lisinopril | 284 | 62 |
| Buspirone Hcl | Buspirone Hcl | 261 | 61 |
| Sertraline Hcl | Sertraline Hcl | 245 | 61 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 199 | 31 |
| Hydralazine Hcl | Hydralazine Hcl | 195 | 45 |
| Quetiapine Fumarate | Quetiapine Fumarate | 194 | 45 |
| Xarelto | Rivaroxaban | 189 | 17 |
| Memantine Hcl | Memantine Hcl | 172 | 36 |
| Simvastatin | Simvastatin | 167 | 24 |
| Midodrine Hcl | Midodrine Hcl | 158 | 41 |
| Baclofen | Baclofen | 156 | 39 |
| Ondansetron Hcl | Ondansetron Hcl | 150 | 62 |
| Cefdinir | Cefdinir | 148 | 99 |
| Alendronate Sodium | Alendronate Sodium | 142 | 27 |
| Escitalopram Oxalate | Escitalopram Oxalate | 141 | 36 |
| Gemtesa | Vibegron | 140 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 133 | 56 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 130 | 20 |
| Finasteride | Finasteride | 127 | 22 |
| Lorazepam | Lorazepam | 125 | 21 |
| Doxycycline Hyclate | Doxycycline Hyclate | 124 | 70 |
| Spironolactone | Spironolactone | 124 | 25 |
| Latanoprost | Latanoprost | 123 | 27 |
| Tramadol Hcl | Tramadol Hcl | 123 | 35 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 121 | 16 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 118 | 18 |
| Lactulose | Lactulose | 117 | 27 |
| Metoprolol Succinate | Metoprolol Succinate | 117 | 38 |
| Montelukast Sodium | Montelukast Sodium | 116 | 21 |
| Risperidone | Risperidone | 116 | 18 |
| Bumetanide | Bumetanide | 114 | 21 |
| Warfarin Sodium | Warfarin Sodium | 112 | suppressed |
| Prednisone | Prednisone | 103 | 39 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 102 | 23 |
| Duloxetine Hcl | Duloxetine Hcl | 98 | 21 |
| Jardiance | Empagliflozin | 95 | 12 |
| Azithromycin | Azithromycin | 94 | 50 |
| Ceftriaxone | Ceftriaxone Sodium | 92 | 58 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 89 | 18 |
| Ertapenem | Ertapenem Sodium | 87 | 40 |
| Hydrochlorothiazide | Hydrochlorothiazide | 87 | 15 |
| Allopurinol | Allopurinol | 74 | 14 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 74 | 25 |
| Torsemide | Torsemide | 74 | 12 |
| Nystatin | Nystatin | 73 | 39 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 72 | 47 |
| Entresto | Sacubitril/Valsartan | 72 | suppressed |
| Novolog Flexpen | Insulin Aspart | 71 | 17 |
| Trulicity | Dulaglutide | 69 | 12 |
| Albuterol Sulfate | Albuterol Sulfate | 68 | 17 |
| Januvia | Sitagliptin Phosphate | 68 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 67 | 16 |
| Ezetimibe | Ezetimibe | 65 | 13 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 64 | 24 |
| Lidocaine Hcl | Lidocaine Hcl | 64 | 45 |
| Pravastatin Sodium | Pravastatin Sodium | 64 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 61 | 32 |
| Clonidine Hcl | Clonidine Hcl | 61 | 22 |
| Atenolol | Atenolol | 60 | 11 |
| Nifedipine Er | Nifedipine | 60 | 11 |
| Ondansetron Odt | Ondansetron | 59 | suppressed |
| Omeprazole | Omeprazole | 58 | 15 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 56 | 14 |
| Methocarbamol | Methocarbamol | 56 | 19 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 56 | 13 |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 55 | 14 |
| Fluoxetine Hcl | Fluoxetine Hcl | 55 | suppressed |
| Ketoconazole | Ketoconazole | 55 | 23 |
| Glipizide | Glipizide | 54 | 11 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 54 | 20 |
| Myrbetriq | Mirabegron | 54 | suppressed |
| Xtampza Er | Oxycodone Myristate | 53 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 52 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 51 | 24 |
| Citalopram Hbr | Citalopram Hydrobromide | 50 | 13 |
| Doxazosin Mesylate | Doxazosin Mesylate | 49 | suppressed |
| Famotidine | Famotidine | 49 | 23 |
| Fenofibrate | Fenofibrate Nanocrystallized | 49 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 49 | 16 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 49 | 16 |
| Lokelma | Sodium Zirconium Cyclosilicate | 49 | suppressed |
| Ranolazine Er | Ranolazine | 49 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 47 | 15 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 46 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 45 | 11 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 45 | 20 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 44 | suppressed |
| Fluconazole | Fluconazole | 44 | 35 |
| Lamotrigine | Lamotrigine | 44 | suppressed |
| Timolol Maleate | Timolol Maleate | 44 | suppressed |
| Oxycontin | Oxycodone Hcl | 43 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 42 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 42 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 42 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 42 | 26 |
| Acetazolamide | Acetazolamide | 39 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 39 | suppressed |
| Cephalexin | Cephalexin | 38 | 28 |
| Oxycodone Hcl | Oxycodone Hcl | 38 | 11 |
| Diclofenac Sodium | Diclofenac Sodium | 37 | 16 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 36 | suppressed |
| Alprazolam | Alprazolam | 34 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 34 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 34 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 34 | 13 |
| Aripiprazole | Aripiprazole | 33 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 33 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 33 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 32 | suppressed |
| Olanzapine | Olanzapine | 32 | 12 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 32 | suppressed |
| Rexulti | Brexpiprazole | 32 | suppressed |
| Admelog Solostar | Insulin Lispro | 31 | suppressed |
| Enulose | Lactulose | 31 | 12 |
| Metformin Hcl Er | Metformin Hcl | 31 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 31 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 30 | suppressed |
| Insulin Lispro | Insulin Lispro | 30 | 21 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 30 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 29 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 29 | suppressed |
| Topiramate | Topiramate | 29 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 28 | 13 |
| Meloxicam | Meloxicam | 28 | suppressed |
| Procrit | Epoetin Alfa | 28 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 27 | suppressed |
| Brilinta | Ticagrelor | 27 | suppressed |
| Glimepiride | Glimepiride | 27 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 26 | 18 |
| Cilostazol | Cilostazol | 26 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 26 | suppressed |
| Lacosamide | Lacosamide | 25 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 25 | 14 |
| Clonazepam | Clonazepam | 24 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 24 | suppressed |
| Methotrexate | Methotrexate Sodium | 24 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 23 | suppressed |
| Entacapone | Entacapone | 23 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 23 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 23 | suppressed |
| Phenytoin | Phenytoin | 23 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 23 | suppressed |
| Sucralfate | Sucralfate | 23 | suppressed |
| Budesonide | Budesonide | 22 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 22 | 14 |
| Dorzolamide Hcl | Dorzolamide Hcl | 22 | suppressed |
| Fenofibrate | Fenofibrate | 22 | suppressed |
| Levofloxacin | Levofloxacin | 22 | 15 |
| Linzess | Linaclotide | 22 | suppressed |
| Naloxone Hcl | Naloxone Hcl | 22 | 20 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 22 | suppressed |
| Tacrolimus | Tacrolimus | 22 | suppressed |
| Verquvo | Vericiguat | 22 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 21 | suppressed |
| Carbamazepine Er | Carbamazepine | 21 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 21 | suppressed |
| Calcitriol | Calcitriol | 20 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 20 | suppressed |
| Estradiol | Estradiol | 20 | suppressed |
| Glatopa | Glatiramer Acetate | 20 | suppressed |
| Humalog | Insulin Lispro | 20 | 12 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 20 | 16 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 20 | suppressed |
| Vyzulta | Latanoprostene Bunod | 20 | suppressed |
| Letrozole | Letrozole | 19 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 19 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 19 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 19 | suppressed |
| Armodafinil | Armodafinil | 18 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 18 | suppressed |
| Fluocinolone Acetonide | Fluocinolone Acetonide | 18 | suppressed |
| Nitroglycerin | Nitroglycerin | 18 | 12 |
| Rivastigmine | Rivastigmine Tartrate | 18 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 17 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 17 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 17 | suppressed |
| Bicalutamide | Bicalutamide | 16 | suppressed |
| Glucagon Emergency Kit | Glucagon | 16 | suppressed |
| Hydroxyurea | Hydroxyurea | 16 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 16 | suppressed |
| Ibuprofen | Ibuprofen | 16 | suppressed |
| Ivermectin | Ivermectin | 16 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 16 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 16 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 16 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 16 | suppressed |
| Xifaxan | Rifaximin | 16 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 15 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 15 | suppressed |
| Amoxicillin | Amoxicillin | 14 | 11 |
| Carbamazepine | Carbamazepine | 14 | suppressed |
| Chlorthalidone | Chlorthalidone | 14 | suppressed |
| Dutasteride | Dutasteride | 14 | suppressed |
| Hydrocortisone | Hydrocortisone | 14 | suppressed |
| Novolog | Insulin Aspart | 14 | suppressed |
| Permethrin | Permethrin | 14 | 11 |
| Relistor | Methylnaltrexone Bromide | 14 | suppressed |
| Acyclovir | Acyclovir | 13 | suppressed |
| Anastrozole | Anastrozole | 13 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 13 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 13 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 13 | suppressed |
| Colchicine | Colchicine | 13 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 13 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 13 | suppressed |
| Glipizide Er | Glipizide | 13 | suppressed |
| Ingrezza | Valbenazine Tosylate | 13 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 13 | suppressed |
| Metolazone | Metolazone | 13 | suppressed |
| Mupirocin | Mupirocin | 13 | 12 |
| Oxybutynin Chloride | Oxybutynin Chloride | 13 | suppressed |
| Ozempic | Semaglutide | 13 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Admelog | Insulin Lispro | 12 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 12 | suppressed |
| Exemestane | Exemestane | 12 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 12 | suppressed |
| Pregabalin | Pregabalin | 12 | suppressed |
| Propafenone Hcl | Propafenone Hcl | 12 | suppressed |
| Rocklatan | Netarsudil Mesylat/Latanoprost | 12 | suppressed |
| Sotalol | Sotalol Hcl | 12 | suppressed |
| Tradjenta | Linagliptin | 12 | suppressed |
| Zonisamide | Zonisamide | 12 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 11 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 11 | suppressed |
| Bromocriptine Mesylate | Bromocriptine Mesylate | 11 | suppressed |
| Celecoxib | Celecoxib | 11 | suppressed |
| Clozapine | Clozapine | 11 | suppressed |
| Dextrose 5%-0.45% Nacl | Dextrose 5 %-0.45 % Sod Chlord | 11 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 11 | suppressed |
| Mounjaro | Tirzepatide | 11 | suppressed |
| Scopolamine | Scopolamine | 11 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 11 | suppressed |
| Steglatro | Ertugliflozin Pidolate | 11 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $20.58 · 1 records | Otsuka America Pharmaceutical, Inc. | REXULTI | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Rexulti play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Otsuka America Pharmaceutical, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error